Sarim Khan, Co-founder and CEO at Triomics, shared a post on LinkedIn:
“We’re excited to share that the Mount Sinai Tisch Cancer Center has launched our PRISM platform to help connect more patients across the Mount Sinai Health System to clinical trials.
What’s especially meaningful about this deployment is the systemwide approach. Patients receiving care at Mount Sinai locations across NYC and beyond can be considered earlier and more consistently for the same research opportunities.
Huge thanks to Dr. Karyn Goodman, the Tisch Cancer Center team, Mount Sinai Research IT, and Therica Miller (we’ll miss you) for the partnership and thoughtful governance to bring this live. We’re excited to assess the impact and share learnings as the program scales.”
More posts featuring Mount Sinai.